In a study conducted by Novavax, an American biotech company, their vaccine has shown 89% effectiveness on the U.K. variant of the virus, tested on 15,000 U.K. volunteers. This is in contrast…
Bennett Doughty, Binghamton University, State University of New York and Pamela Stewart Fahs, Binghamton University, State University of New York The enormous job of vaccinating the nation is underway, but for rural…
David Pride, University of California San Diego SARS-CoV-2, the virus that causes the respiratory illness COVID-19, has killed approximately 2.2% of those worldwide who are known to have contracted it. But the…